the present study evaluated the antihyperglycemic and lipidlowering properties of emblica officinalis gaertnfruit in normal and diabetic human volunteersthe results indicated a significant decrease p   005 in fasting and 2h postprandial blood glucose levels on the 21st day in both normal and diabetic subjects receiving 1 2 or 3 g e officinalis powder per day as compared with their baseline valuessignificant p   005 decreases were also observed in total cholesterol and triglycerides in both normal and diabetic volunteers on day 21 that were given either 2 or 3 g e officinalis powder per dayhowever diabetic volunteers receiving only 3 g e officinalis powder exhibited a significant p   005 decrease in total lipids on day 21both normal and diabetic volunteers receiving 2 or 3 g e officinalis powder significantly p   005 improved highdensity lipoproteincholesterol and lowered lowdensity lipoproteincholesterol levels